Regenerative protocols are most consequential in cases where the standard approach — conventional GBR, standard graft material, routine wound closure — is unlikely to produce the volume or quality of tissue required for long-term implant stability and aesthetic outcomes.
These include: large-volume vertical bone defects where standard membranes are insufficient; complex extraction sites with multi-wall defects and thin buccal cortex; peri-implant bone defects following surgical decontamination; and soft tissue augmentation in patients with thin biotype and compromised healing capacity.
The integration of PRF or CGF into these cases — combined with appropriate biomaterial selection and microsurgical wound management — consistently produces superior early wound healing, reduced membrane exposure rates, and enhanced tissue volume at reopening.
The decision to use a regenerative protocol is made during digital planning — not at the surgical visit. CBCT assessment of the defect morphology, tissue biotype evaluation, and patient-specific factors (healing capacity, smoking, systemic health) determine which combination of approaches is indicated and what the realistic regenerative ceiling is.